Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 3 of 3 entries
View as:
Phase: N/A
Priority: Normal
Start: 01/30/19
End: 05/31/20
Due: 05/31/21
Phase: N/A
Priority: Normal
Start: 05/26/20
End: 07/31/20
Due: 07/31/21
Phase: N/A
Priority: Normal
Start: 06/14/19
End: 12/14/19
Due: 12/14/20
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Safety, Tolerability and Pharmacokinetics of AD16 Tablets in Adult Healthy Subjects After Single Administration | NCT05787028 | South China Center For Innovative Pharmaceuticals | user2@example.com | None | 2019-01-30 | 2020-05-31 | 2021-05-31 | - | - | 2025-07-14 |
| Safety, Tolerability and Pharmacokinetics of AD16 Tablets After MAD in Healthy Chinese Adult Subjects | NCT05806177 | South China Center For Innovative Pharmaceuticals | user2@example.com | None | 2020-05-26 | 2020-07-31 | 2021-07-31 | - | - | 2025-07-14 |
| The Effect of High Fat Diet on the Pharmacokinetics of AD16 Tablets in Healthy Chinese Adult Subjects | NCT05787041 | South China Center For Innovative Pharmaceuticals | user2@example.com | None | 2019-06-14 | 2019-12-14 | 2020-12-14 | - | - | 2025-07-14 |